A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Triple Negative Breast Neoplasms

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • USA Mitchell Cancer Institute ( Site 0090), Mobile, Alabama, United States

    Study coordinator · 251-410-4924
  • Ironwood Cancer & Research Centers ( Site 0036), Chandler, Arizona, United States

    Study coordinator · 623-312-3000
  • City of Hope ( Site 0097), Duarte, California, United States

    Study coordinator · 626-218-9845
  • City of Hope Lennar Foundation Cancer Center ( Site 0099), Irvine, California, United States

    Study coordinator · 626-218-0720
  • UCLA Department of Medicine - Hematology & Oncology ( Site 0047), Los Angeles, California, United States

    Study coordinator · 650-283-5067
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0016), San Francisco, California, United States

    Study coordinator · 415-353-7070
  • Yale New Haven Hospital ( Site 0001), New Haven, Connecticut, United States

  • Washington Hospital Center ( Site 0098), Washington D.C., District of Columbia, United States

    Study coordinator · 202-877-8839
  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs, Florida, United States

    Study coordinator · 407-303-2284
  • Orlando Health Cancer Institute ( Site 0012), Orlando, Florida, United States

    Study coordinator · 321-841-8284
  • Florida Cancer Specialists - East ( Site 7000), West Palm Beach, Florida, United States

    Study coordinator · 561-366-4100
  • University Cancer & Blood Center, LLC ( Site 0023), Athens, Georgia, United States

    Study coordinator · 706-353-2990
  • St. Luke's Cancer Institute: Boise ( Site 0037), Boise, Idaho, United States

    Study coordinator · 208-381-2711
  • University of Illinois Cancer Center ( Site 0044), Chicago, Illinois, United States

    Study coordinator · 312-996-1581
  • MedStar Franklin Square Medical Center ( Site 0031), Baltimore, Maryland, United States

    Study coordinator · 443-777-7147
  • MedStar Good Samaritan Hospital ( Site 0079), Baltimore, Maryland, United States

    Study coordinator · 443-777-7147
  • MedStar Southern Maryland Hospital Center ( Site 0100), Clinton, Maryland, United States

    Study coordinator · 301-877-4673
  • MedStar Montgomery Medical Center ( Site 0078), Olney, Maryland, United States

    Study coordinator · 301-774-8882
  • Holy Cross Hospital ( Site 0091), Silver Spring, Maryland, United States

    Study coordinator · 301-754-7552
  • Cancer & Hematology Centers of Western Michigan ( Site 0026), Grand Rapids, Michigan, United States

    Study coordinator · 616-954-9800
  • Allina Health Cancer Institute ( Site 0069), Minneapolis, Minnesota, United States

    Study coordinator · 763-577-7000
  • Comprehensive Cancer Centers of Nevada ( Site 0015), Las Vegas, Nevada, United States

    Study coordinator · 702-952-3350
  • Renown Regional Medical Center ( Site 0005), Reno, Nevada, United States

    Study coordinator · 775-982-5050
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0082), Hackensack, New Jersey, United States

    Study coordinator · 551-996-5900
  • New Mexico Oncology Hematology Consultants Ltd. ( Site 0019), Albuquerque, New Mexico, United States

    Study coordinator · 505-842-8171
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola, New York, United States

    Study coordinator · 516-663-9500
  • Laura and Isaac Perlmutter Cancer Center ( Site 0003), New York, New York, United States

    Study coordinator · 212-731-6126
  • UNC REX Cancer Center ( Site 0071), Raleigh, North Carolina, United States

    Study coordinator · 919-784-7209
  • SCRI Oncology Partners ( Site 7004), Nashville, Tennessee, United States

    Study coordinator · 615-329-7274
  • Tennessee Oncology ( Site 0018), Nashville, Tennessee, United States

    Study coordinator · 877-836-6662
  • Texas Oncology - DFW ( Site 8007), Dallas, Texas, United States

    Study coordinator · 214-739-4175
  • Texas Oncology - West Texas ( Site 8004), El Paso, Texas, United States

    Study coordinator · 915-747-4835
  • Kelsey-Seybold Clinic - North Houston Campus ( Site 0096), Houston, Texas, United States

    Study coordinator · 713-239-4510
  • Kelsey-Seybold Clinic ( Site 0040), Houston, Texas, United States

    Study coordinator · 713-239-4510
  • Texas Oncology - San Antonio ( Site 8001), San Antonio, Texas, United States

    Study coordinator · 210-419-2608
  • University of Utah, Huntsman Cancer Institute ( Site 0056), Salt Lake City, Utah, United States

    Study coordinator · 801-587-7000
  • Virginia Oncology Associates (VOA) ( Site 8002), Norfolk, Virginia, United States

    Study coordinator · 757-368-5033
  • Fred Hutchinson Cancer Center ( Site 0042), Seattle, Washington, United States

    Study coordinator · 206-606-6329
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 2401), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +54 9223 593 7663
  • Instituto Alexander Fleming ( Site 2402), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +541132218900
  • Hospital Italiano de Cordoba ( Site 2406), Córdoba, Córdoba Province, Argentina

    Study coordinator · +543514106550
  • Clinica Viedma ( Site 2403), Viedma, Río Negro Province, Argentina

    Study coordinator · 54 9351 592 3598
  • Fundacion Estudios Clinicos ( Site 2405), Rosario, Santa Fe Province, Argentina

    Study coordinator · +54 9346 69 9922
  • Hospital Provincial del Centenario ( Site 2410), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414307185
  • Fundacion Centro Oncologico de Integración Regional ( Site 2400), Mendoza, Argentina

    Study coordinator · +54 9261 367 9497
  • Blacktown Hospital ( Site 5500), Blacktown, New South Wales, Australia

    Study coordinator · +61298818000
  • Peninsula Health Frankston Hospital ( Site 5501), Frankston, Victoria, Australia

    Study coordinator · +61397848520
  • ZAS Sint Augustinus ( Site 3102), Antwerp, Flanders, Belgium

    Study coordinator · 003234433759
  • Ziekenhuis Oost Limburg ( Site 3105), Genk, Limburg, Belgium

    Study coordinator · 089 32 50 50
  • AZ Maria Middelares ( Site 3103), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 9 246 95 16
  • UZ Gent ( Site 3101), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · 09 332 20 15
  • Hospital de Câncer de Recife ( Site 2300), Recife, Pernambuco, Brazil

    Study coordinator · +558132178084
  • Liga Norte Riograndense Contra o Cancer ( Site 2310), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +55 84 99817-0070
  • Hospital Nossa Senhora da Conceição ( Site 2302), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +55 51 35160954
  • Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 2307), Barretos, São Paulo, Brazil

    Study coordinator · +55 17 3321-6637
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 2301), São Jose Do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 (17) 3201-5054
  • IBCC - Núcleo de Pesquisa e Ensino ( Site 2306), São Paulo, Brazil

    Study coordinator · +55 11 98468-0001
  • Cross Cancer Institute ( Site 0216), Edmonton, Alberta, Canada

    Study coordinator · 7804328644
  • Lakeridge Health ( Site 0217), Oshawa, Ontario, Canada

    Study coordinator · 905-576-8711
  • North York General Hospital ( Site 0209), Toronto, Ontario, Canada

    Study coordinator · 416-756-6000
  • Princess Margaret Cancer Centre ( Site 0202), Toronto, Ontario, Canada

    Study coordinator · 416-946-2000
  • CIUSSS- saguenay-Lac-Saint-Jean ( Site 0213), Chicoutimi, Quebec, Canada

    Study coordinator · 418-541-1000
  • Centre Hospitalier de l'Université de Montréal ( Site 0208), Montreal, Quebec, Canada

    Study coordinator · 514-890-8444
  • Jewish General Hospital ( Site 0203), Montreal, Quebec, Canada

    Study coordinator · 514-340-8222
  • St. Marys Hospital Center ( Site 0201), Montreal, Quebec, Canada

    Study coordinator · 514-891-6904
  • McGill University Health Centre ( Site 0204), Montreal, Quebec, Canada

    Study coordinator · 514-299-6425
  • Hopital Du Saint-Sacrement ( Site 0210), Québec, Quebec, Canada

    Study coordinator · 4186827511
  • Saskatoon Cancer Centre ( Site 0215), Saskatoon, Saskatchewan, Canada

    Study coordinator · 306-655-2662
  • Biocenter ( Site 2009), Concepción, Biobio, Chile

    Study coordinator · +56412858421
  • IC La Serena Research ( Site 2007), La Serena, Coquimbo Region, Chile

    Study coordinator · +56512386127
  • FALP ( Site 2000), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56 9 6397 7440
  • Clínica UC San Carlos de Apoquindo ( Site 2008), Santiago, Region M. de Santiago, Chile

    Study coordinator · +569 5504 3334
  • Bradfordhill ( Site 2001), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56978878489
  • ONCOCENTRO APYS ( Site 2005), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56 9 92369820
  • The First Afflilated Hospital of Bengbu Medical College ( Site 5022), Bengbu, Anhui, China

    Study coordinator · 0552-3085746
  • The First Affiliated Hospital of Chongqing Medical University ( Site 5039), Chongqing, Chongqing Municipality, China

    Study coordinator · +86 023 89011606
  • Chongqing University Three Gorges Hospital ( Site 5020), Chongqing, Chongqing Municipality, China

    Study coordinator · 023-58103215
  • The First Affiliated hospital of Xiamen University ( Site 5035), Xiamen, Fujian, China

    Study coordinator · 0592-2137232
  • Sun Yat-Sen University Cancer Center ( Site 5014), Guangzhou, Guangdong, China

    Study coordinator · 020-87343990
  • Guangxi Medical University Affiliated Tumor Hospital. ( Site 5008), Nanning, Guangxi, China

    Study coordinator · +860771-5778582
  • Henan Cancer Hospital ( Site 5001), Zhengzhou, Henan, China

    Study coordinator · 0371-65588404
  • Tongji Hospital Tongji Medical Science & Technology ( Site 5007), Wuhan, Hubei, China

    Study coordinator · 027-83663940
  • Xiangyang Central Hospital ( Site 5017), Xiangyang, Hubei, China

    Study coordinator · 0710-2811523
  • Hunan Cancer Hospital ( Site 5002), Changsha, Hunan, China

    Study coordinator · 0731-88651669
  • Jiangsu Province Hospital ( Site 5009), Nanjing, Jiangsu, China

    Study coordinator · 02568308145
  • Xuzhou Central Hospital ( Site 5036), Xuzhou, Jiangsu, China

    Study coordinator · 051680812397
  • The First Hospital of Jilin University ( Site 5003), Changchun, Jilin, China

    Study coordinator · 0431-88783330
  • The First Affiliated Hospital of Xi an Jiaotong University ( Site 5005), Xi'an, Shaanxi, China

    Study coordinator · +8602985324094
  • Jinan Central Hospital ( Site 5031), Jinan, Shandong, China

    Study coordinator · 053155865197
  • LinYi Cancer Hospital ( Site 5021), Linyi, Shandong, China

    Study coordinator · +8605398127192
  • Shanxi Cancer Hospital ( Site 5043), Taiyuan, Shanxi, China

    Study coordinator · 03514881611
  • Sichuan Cancer Hospital. ( Site 5018), Chengdu, Sichuan, China

    Study coordinator · 028-85420251
  • The Second People's Hospital of Neijiang ( Site 5016), Neijiang, Sichuan, China

    Study coordinator · +86 0832 2380771
  • Affiliated Tumor Hospital of Xinjiang Medical University ( Site 5006), Ürümqi, Xinjiang, China

    Study coordinator · +8609917819133
  • The First Affiliated Hospital Zhejiang University School of Medicine ( Site 5026), Hangzhou, Zhejiang, China

    Study coordinator · 0571-87236855
  • Zhejiang Cancer Hospital ( Site 5012), Hangzhou, Zhejiang, China

    Study coordinator · 0571-88122222
  • The Second Affiliated hospital of Zhejiang University school of medicine ( Site 5024), Hangzhou, Zhejiang, China

    Study coordinator · 0571-89713252
  • Taizhou Hospital of Zhejiang Province ( Site 5029), Linhai, Zhejiang, China

    Study coordinator · 0576-85190467
  • Instituto de Cancerología ( Site 2206), Medellín, Antioquia, Colombia

    Study coordinator · +576043421010x1089
  • Centro Cancerologico del Caribe LTD ( Site 2209), Barranquilla, Atlántico, Colombia

    Study coordinator · +57 3132121774
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2203), Bogotá, Bogota D.C., Colombia

    Study coordinator · +57 6017454421x90614
  • IMAT S.A.S ( Site 2202), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +576047862333
  • Oncologos Del Occidente ( Site 2208), Pereira, Risaralda Department, Colombia

    Study coordinator · 573154208077
  • Fakultni nemocnice Ostrava ( Site 3505), Ostrava - Poruba, Moravian-Silesian Region, Czechia

    Study coordinator · +420597372124
  • Vseobecna fakultni nemocnice v Praze ( Site 3501), Prague, Praha 2, Czechia

    Study coordinator · +420224966764
  • Masarykuv onkologicky ustav ( Site 3500), Brno, South Moravian, Czechia

    Study coordinator · +420543134003
  • Fakultni nemocnice Olomouc ( Site 3502), Olomouc, Czechia

    Study coordinator · +420588444295
  • Fakultni Thomayerova nemocnice ( Site 3506), Prague, Czechia

    Study coordinator · +420261083733
  • Fakultni nemocnice v Motole ( Site 3503), Prague, Czechia

    Study coordinator · +420224434700
  • Rigshospitalet University Hospital ( Site 3201), Copenhagen, Capital Region, Denmark

    Study coordinator · +4535453545
  • Herlev og Gentofte Hospital. ( Site 3205), Copenhagen, Capital Region, Denmark

    Study coordinator · +4538683868
  • Aarhus Universitets hospital ( Site 3204), Aarhus, Central Jutland, Denmark

    Study coordinator · + 4578450000
  • Odense Universitetshospital ( Site 3202), Odense, Region Syddanmark, Denmark

    Study coordinator · +4566113333
  • Oulun yliopistollinen sairaala-Oncology and Hematology ( Site 3304), Oulu, North Ostrobothnia, Finland

    Study coordinator · +35883153038
  • Tampereen yliopistollinen sairaala-Oncology ( Site 3302), Tampere, Pirkanmaa, Finland

    Study coordinator · +358331166764
  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 3301), Helsinki, Uusimaa, Finland

    Study coordinator · +358947174900
  • CENTRE LEON BERARD ( Site 3004), Lyon, Auvergne-Rhône-Alpes, France

    Study coordinator · +33469856440
  • Clinique Francois Chenieux ( Site 3006), Limoges, Haute-Vienne, France

    Study coordinator · +33555058606
  • Institut Regional du Cancer Montpellier ( Site 3009), Montpellier, Herault, France

    Study coordinator · +33(0)4 67 61 45 65
  • Institut De Cancerologie De L Ouest ( Site 3003), Saint-Herblain, Loire-Atlantique, France

    Study coordinator · +33240679900
  • Institut Jean Godinot ( Site 3002), Reims, Marne, France

    Study coordinator · +33326504444
  • Centre Henri Becquerel ( Site 3001), Rouen, Seine-Maritime, France

    Study coordinator · +33232082575
  • HIA Sainte Anne ( Site 3007), Toulon, Var, France

    Study coordinator · +33483162010
  • Groupe Hospitalier Paris Saint Joseph ( Site 3010), Paris, France

    Study coordinator · +33144123577
  • Hôpital Européen Georges Pompidou ( Site 3011), Paris, France

    Study coordinator · +33156093577
  • Universitatsklinikum Erlangen ( Site 4302), Erlangen, Bavaria, Germany

    Study coordinator · +4991318544082
  • Luisenkrankenhaus Düsseldorf ( Site 4305), Düsseldorf, North Rhine-Westphalia, Germany

    Study coordinator · +4921144773360
  • Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 4304), Essen, North Rhine-Westphalia, Germany

    Study coordinator · +492011740
  • Caritas Klinikum Saarbruecken St. Theresia ( Site 4301), Saarbrücken, Saarland, Germany

    Study coordinator · +496814061345
  • Universitaetsklinikum Leipzig ( Site 4307), Leipzig, Saxony, Germany

    Study coordinator · +4934197109
  • HELIOS Klinikum Berlin-Buch ( Site 4303), Berlin, Germany

    Study coordinator · +4930940153300
  • Aretaieio Hospital ( Site 3900), Athens, Attica, Greece

    Study coordinator · 0030 2107286444
  • University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 3903), Heraklion, Irakleio, Greece

    Study coordinator · 0030 2810392091
  • General University Hospital of Larissa, Oncology Clinic ( Site 3902), Larissa, Thessaly, Greece

    Study coordinator · 0030 2413501636
  • European Interbalkan Medical Center ( Site 3901), Thessaloniki, Greece

    Study coordinator · 0030 2313252011
  • Queen Mary Hospital ( Site 6000), Hong Kong, Hong Kong

    Study coordinator · 39103339
  • Békés Vármegyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 3405), Gyula, Bekes County, Hungary

    Study coordinator · +36 66/526-526
  • Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterapias Klinika ( Site 3407), Szeged, Csongrád megye, Hungary

    Study coordinator · +3662545404
  • Budapesti Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 3408), Budapest, Pest County, Hungary

    Study coordinator · +36 1 467-3700/1245
  • Országos Onkológiai Intézet-B-Belgyógyászati Onkológiai Osztály ( Site 3406), Budapest, Hungary

    Study coordinator · +36122486003352
  • Rambam Health Care Campus ( Site 3700), Haifa, Israel

    Study coordinator · +97247772688
  • Shaare Zedek Medical Center ( Site 3704), Jerusalem, Israel

    Study coordinator · +97226555999
  • Rabin Medical Center ( Site 3702), Petah Tikva, Israel

    Study coordinator · +97239377377
  • Sheba Medical Center ( Site 3701), Ramat Gan, Israel

    Study coordinator · +97235303030
  • Sourasky Medical Center ( Site 3703), Tel Aviv, Israel

    Study coordinator · +97236974444
  • Istituto Nazionale Tumori Regina Elena ( Site 4607), Rome, Roma, Italy

    Study coordinator · +39 0652665610
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 4605), Bologna, Italy

    Study coordinator · 390512144547
  • Ospedale Policlinico San Martino ( Site 4606), Genova, Italy

    Study coordinator · +390105600387
  • IRCCS Ospedale San Raffaele ( Site 4600), Milan, Italy

    Study coordinator · 390226436530
  • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 4601), Milan, Italy

    Study coordinator · +39 02-2390-2849
  • Azienda Ospedaliero Universitaria Maggiore della Carità ( Site 4604), Novara, Italy

    Study coordinator · 3903213732148
  • Istituto Oncologico Veneto IRCCS ( Site 4603), Padova, Italy

    Study coordinator · 0498215523
  • Policlincio Gemelli ( Site 4602), Roma, Italy

    Study coordinator · 0630158545
  • Aichi Cancer Center ( Site 5117), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111
  • Nagoya City University Hospital ( Site 5108), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-851-5511
  • National Hospital Organization Shikoku Cancer Center ( Site 5122), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Hokkaido University Hospital ( Site 5100), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161
  • Kanazawa Medical University Hospital ( Site 5127), Kahoku-gun, Ishikawa-ken, Japan

    Study coordinator · +81-76-286-3511
  • Tokai University Hospital ( Site 5107), Isehara, Kanagawa, Japan

    Study coordinator · +81-463-93-1121
  • St. Marianna University Hospital ( Site 5124), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kitasato University Hospital ( Site 5123), Sagamihara, Kanagawa, Japan

    Study coordinator · +81-42-778-8111
  • Kanagawa Cancer Center ( Site 5106), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Mie University Hospital ( Site 5109), Tsu, Mie-ken, Japan

    Study coordinator · +81-59-231-5246
  • Naha Nishi Clinic ( Site 5125), Naha, Okinawa, Japan

    Study coordinator · +81-98-858-5557
  • The University of Osaka Hospital ( Site 5111), Suita, Osaka, Japan

    Study coordinator · +81-6-6210-8290
  • Saitama Medical University International Medical Center ( Site 5116), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Juntendo University Hospital ( Site 5104), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • Cancer Institute Hospital of JFCR ( Site 5102), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Toranomon Hospital ( Site 5126), Minato, Tokyo, Japan

    Study coordinator · +81-3-3588-1111
  • Showa Medical University Hospital ( Site 5103), Shinagawa, Tokyo, Japan

    Study coordinator · +81-3-3784-8000
  • Tokyo Medical University Hospital ( Site 5121), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Center for Global Health and Medicine ( Site 5105), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3202-7181
  • Akita University Hospital ( Site 5115), Akita, Japan

    Study coordinator · +81-18-834-1111
  • National Hospital Organization Kyushu Cancer Center ( Site 5119), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 5101), Fukushima, Japan

    Study coordinator · +81-24-547-1772
  • Hiroshima City Hiroshima Citizens Hospital ( Site 5113), Hiroshima, Japan

    Study coordinator · +81-81-221-2291
  • Social medical corporation Hakuaikai Sagara Hospital ( Site 5114), Kagoshima, Japan

    Study coordinator · +81-99-224-1800
  • Kyoto University Hospital ( Site 5110), Kyoto, Japan

    Study coordinator · +81-75-751-3111
  • Okayama University Hospital ( Site 5118), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 5112), Osaka, Japan

    Study coordinator · +81-06-6945-1181
  • National Cancer Institute ( Site 5401), Putrajaya, Putrajaya, Malaysia

    Study coordinator · +60388925418
  • Sarawak General Hospital ( Site 5400), Kuching, Sarawak, Malaysia

    Study coordinator · +6082276820
  • Pantai Hospital Kuala Lumpur ( Site 5402), Kuala Lumpur, Malaysia

    Study coordinator · +60322960888
  • University Malaya Medical Centre ( Site 5403), Kuala Lumpur, Malaysia

    Study coordinator · +60479492351
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 2504), Guadalajara, Jalisco, Mexico

    Study coordinator · 3330447001
  • Grupo Médico ASSET ( Site 2507), Mexico City, Mexico City, Mexico

    Study coordinator · 2223813254
  • COI Centro Oncologico Internacional S.A.P.I. de C.V. ( Site 2514), Mexico City, Mexico City, Mexico

    Study coordinator · +525554248970
  • Centro Oncologico de Alta Especialidad, S.C. ( Site 2509), Mexico City, Mexico City, Mexico

    Study coordinator · +52 55 5286 5738
  • Higiea Oncologia ( Site 2505), Mexico City, Mexico City, Mexico

    Study coordinator · +525554137773
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 2501), Monterrey, Nuevo León, Mexico

    Study coordinator · +528125761529
  • Oncare - Unidad Valle ( Site 2502), San Pedro Garza García, Nuevo León, Mexico

    Study coordinator · +528115337180
  • Centro de Investigacion Clinica de Oaxaca ( Site 2503), Oaxaca City, Oaxaca, Mexico

    Study coordinator · +529516035559
  • Centro de Investigación Oncológica Galerías SC ( Site 2511), Aguascalientes, Mexico

    Study coordinator · +524496890593
  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 2510), Chihuahua City, Mexico

    Study coordinator · 526144253458712
  • Centro Potosino de Investigación Médica ( Site 2512), San Luis Potosí City, Mexico

    Study coordinator · 52 444 475 2715
  • Ziekenhuis Rijnstate ( Site 4501), Arnhem, Gelderland, Netherlands

    Study coordinator · +31880056201
  • Zuyderland Medical Centre ( Site 4507), Sittard Geleen, Limburg, Netherlands

    Study coordinator · +31884590400
  • ETZ Elisabeth ( Site 4504), Tilburg, North Brabant, Netherlands

    Study coordinator · +31132210425
  • Deventer Ziekenhuis ( Site 4503), Deventer, Overijssel, Netherlands

    Study coordinator · +31570596437
  • Erasmus Medisch Centrum ( Site 4505), Rotterdam, South Holland, Netherlands

    Study coordinator · +31107041733
  • Meander Medisch Centrum ( Site 4500), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31338507278
  • Martini Ziekenhuis ( Site 4502), Groningen, Netherlands

    Study coordinator · +31505246311
  • Harbour Cancer & Wellness ( Site 5600), Newmarket, Auckland, New Zealand

    Study coordinator · +64 9 220 3333
  • Bowen Icon Cancer Centre ( Site 5601), Crofton Downs, Wellington Region, New Zealand

    Study coordinator · +64 9 479 2069
  • Clínica Internacional - Sede San Borja ( Site 2604), Lima, Peru

    Study coordinator · +51 992004083
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 2601), Lima, Peru

    Study coordinator · +51 997881134
  • Oncosalud ( Site 2600), Lima, Peru

    Study coordinator · +5115137900
  • Hospital Militar Central Coronel Luis Arias Schereiber ( Site 2603), Lima, Peru

    Study coordinator · +5112443453
  • Mary Mediatrix Medical Center ( Site 5702), Lipa, Batangas, Philippines

    Study coordinator · (043) 773 6800
  • THE MEDICAL CITY ILOILO ( Site 5704), Iloilo City, Philippines

    Study coordinator · +6333 3397340
  • Wielkopolskie Centrum Onkologii-Oddział Onkologii Klinicznej i Immunoonkologii z Pododdziałem Dzien ( Site 3811), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48618850620
  • Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 3802), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · +48523743525
  • Pratia MCM Krakow ( Site 3812), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · +48122954100
  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 3801), Siedlce, Masovian Voivodeship, Poland

    Study coordinator · +48256403301
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 3803), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · 48225462522
  • Mazowiecki Szpital Onkologiczny ( Site 3807), Wieliszew, Masovian Voivodeship, Poland

    Study coordinator · +48227661500
  • Bialostockie Centrum Onkologii ( Site 3810), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48733100322
  • Szpitale Pomorskie Sp. z o. o. ( Site 3805), Gdynia, Pomeranian Voivodeship, Poland

    Study coordinator · +48587260380
  • Szpital Wojewodzki im.M.Kopernika. ( Site 3800), Koszalin, West Pomeranian Voivodeship, Poland

    Study coordinator · 48943488931
  • Institutul Oncologic Cluj ( Site 4701), Cluj-Napoca, Cluj, Romania

    Study coordinator · +40264598362
  • S.C. Radiotherapy Center Cluj S.R.L ( Site 4705), Comuna Floresti, Cluj, Romania

    Study coordinator · +40219368
  • Centrul de Oncologie "Sfântul Nectarie" ( Site 4702), Craiova, Dolj, Romania

    Study coordinator · +40731604432
  • Spitalul Municipal Schuller Ploiești ( Site 4707), Ploieşti, Prahova, Romania

    Study coordinator · +40723943507
  • Cabinet Medical Oncomed ( Site 4704), Timișoara, Timiș County, Romania

    Study coordinator · +40356460995
  • Spitalul Clinic Filantropia ( Site 4703), Bucharest, Romania

    Study coordinator · +40213188930
  • Centrul Medical Neolife- Baneasa ( Site 4706), Bucharest, Romania

    Study coordinator · +40219230
  • National Cancer Center ( Site 5202), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82319201623
  • Seoul National University Bundang Hospital ( Site 5204), Seongnam, Kyonggi-do, South Korea

    Study coordinator · 82317877022
  • Kyungpook National University Chilgok Hospital ( Site 5205), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · 82532002625
  • Seoul National University Hospital ( Site 5200), Seoul, South Korea

    Study coordinator · +82220720850
  • Severance Hospital Yonsei University Health System ( Site 5201), Seoul, South Korea

    Study coordinator · +82222288135
  • Samsung Medical Center ( Site 5203), Seoul, South Korea

    Study coordinator · 82234106488
  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 4104), Seville, Andalusia, Spain

    Study coordinator · 34955013068
  • ICO L Hospitalet ( Site 4101), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34932607744
  • Hospital Clinico San Carlos ( Site 4100), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · 34913303000/7768
  • Hospital General Universitario de Valencia ( Site 4102), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · 34963131800/438139
  • Parc de Salut Mar - Hospital del Mar ( Site 4106), Barcelona, Spain

    Study coordinator · 34932483860
  • Hospital Beata María Ana ( Site 4105), Madrid, Spain

    Study coordinator · 914097423/303
  • Hospital Universitario Ramon y Cajal ( Site 4103), Madrid, Spain

    Study coordinator · 913368263
  • Taichung Veterans General Hospital ( Site 5303), Taichung, Taiwan

    Study coordinator · +886-4-2359-2525
  • National Cheng Kung University Hospital ( Site 5304), Tainan, Taiwan

    Study coordinator · +886-6-235-3535
  • National Taiwan University Hospital ( Site 5300), Taipei, Taiwan

    Study coordinator · +886-2-23123456
  • Mackay Memorial Hospital ( Site 5301), Taipei, Taiwan

    Study coordinator · +886-2-25433535
  • Chang Gung Memorial Hospital ( Site 5302), Taoyuan, Taiwan

    Study coordinator · +886-3-328-1200
  • Faculty of Medicine Siriraj Hospital ( Site 5800), Bangkoknoi, Bangkok, Thailand

    Study coordinator · +6624192938
  • Songklanagarind hospital ( Site 5801), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · +6674451469
  • Faculty of Medicine - Khon Kaen University ( Site 5802), Khon Kaen, Thailand

    Study coordinator · +6643363746
  • Ege Universitesi Hastanesi ( Site 4803), Bornova, İzmir, Turkey (Türkiye)

    Study coordinator · 0 232 343 4 343
  • Adana Medical Park Seyhan Hastanesi ( Site 4804), Adana, Turkey (Türkiye)

    Study coordinator · +90 5056166338
  • Hacettepe Universite Hastaneleri ( Site 4800), Ankara, Turkey (Türkiye)

    Study coordinator · 903123052929
  • Gazi University Health Research and Application Center Gazi Hospital ( Site 4805), Ankara, Turkey (Türkiye)

    Study coordinator · 903122158710
  • Sakarya Egitim Arastirma Hsatanesi ( Site 4809), Sakarya, Turkey (Türkiye)

    Study coordinator · 90 505 478 5576
  • Samsun Medical Park Hastanesi ( Site 4810), Samsun, Turkey (Türkiye)

    Study coordinator · 444 44 84
  • Royal Cornwall Hospital ( Site 4003), Truro, Cornwall, United Kingdom

    Study coordinator · +441872258342
  • St Bartholomew's Hospital ( Site 4001), London, London, City of, United Kingdom

    Study coordinator · 02073777000
  • University College London Hospital ( Site 4007), London, London, City of, United Kingdom

    Study coordinator · +447977175703
  • Nottingham University Hospital NHS Trust ( Site 4009), Nottingham, Nottinghamshire, United Kingdom

    Study coordinator · +441159691169
  • Musgrove Park Hospital ( Site 4005), Taunton, Somerset, United Kingdom

    Study coordinator · +441823343634
  • Queen Elizabeth Hospital Birmingham ( Site 4017), Birmingham, United Kingdom

    Study coordinator · +441213718766
  • Velindre Cancer Centre Hospital ( Site 4008), Cardiff, United Kingdom

    Study coordinator · +442920615888
  • St. James s University Hospital ( Site 4004), Leeds, United Kingdom

    Study coordinator · +441132068186
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC